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AbsTrACT
Introduction HIV-exposed children show signs of 
developmental delay. We assessed the impact of a 
pragmatic multicomponent intervention for caregivers of 
HIV-exposed children aged 0–2 years in Zimbabwe.
Methods We conducted a cluster-randomised trial from 
2016 to 2018. Clusters were catchments surrounding 
clinics, allocated (1:1) to either National HIV guidelines 
standard of care or standard care plus an 18-session 
group intervention comprising i) early childhood stimulation 
(ECS) and parenting training with home visits to reinforce 
skills and retention in HIV care; ii) economic strengthening. 
Primary outcomes measured 12 months after baseline 
(4.5 months postintervention completion) included: i) 
global child development measured using the Mullen early 
learning composite score; ii) retention in HIV care. Analysis 
used mixed effects regression to account for clustering and 
adjusted minimally for baseline prognostic factors and was 
by intention to treat.
results Thirty clusters, 15 in each arm, were randomised. 
574 dyads were recruited with 89.5% retained at 
follow-up. Ninety one of 281 (32.4%) were recorded as 
having received the complete intervention package, with 
161/281 (57.3%) attending ≥14 ECS sessions. There 
was no evidence of an intervention effect on global child 
development (intervention mean 88.1 vs standard of care 
mean 87.6; adjusted mean difference=0.06; 95% CI −2.68 
to 2.80; p=0.97) or infant retention in care (proportion 
of children who had missed their most recent HIV test: 
intervention 21.8% vs standard of care 16.9%, p=0.18). 
There was weak evidence that the proportion of caregivers 
with parental stress was reduced in the intervention arm 
(adjusted OR (aOR)=0.69; 95% CI 0.45 to 1.05; p=0.08) 
and stronger evidence that parental distress specifically 
was reduced (intervention arm 17.4% vs standard of care 
29.1% scoring above the cut-off; aOR=0.56; 95% CI 0.35 
to 0.89; p=0.01).
Conclusion This multicomponent intervention had no 
impact on child development outcomes within 4.5 months 
of completion, but had an impact on parental distress. 
Maternal mental health remains a high priority.
Trial registration number PACTR201701001387209.
InTroduCTIon
Early childhood development (ECD) 
covering the first 3 years of a child’s life marks 
a time of gradual development of a child’s 
sensorimotor, social-emotional, cognitive 
and language capacities. These processes 
are shaped by many factors, including inter-
actions between the child and their environ-
ment, exposure to experiences and genetics.1 
During this period of rapid physical growth, 
the child acquires a complex set of skills and 
functional competencies facilitating achieve-
ment of their potential in life and laying the 
Key questions
What is already known?
 ► HIV-exposed children in resource-limited settings 
face multiple and complex stressors associated di-
rectly and indirectly with HIV infection.
 ► Early interventions for HIV-exposed children have led 
to documented improvements in child outcomes in 
the short term and long term.
What are the new findings?
 ► The intervention trialled here did not have an impact 
on child cognitive development, but reduced paren-
tal distress which could directly and indirectly im-
pact child trajectories.
 ► The prevalence of reported symptoms of common 
mental disorder was extremely high among partic-
ipating caregivers.
What do the new findings imply?
 ► Cognitive development outcomes may take longer to 
improve following parental child stimulation training.
 ► Comprehensive interventions to address childhood 
development may need to include screening and in-
tervention for poor mental health in caregivers.
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foundation for long-term physical, emotional and psycho-
logical health in childhood and adulthood.
During this period, children’s brains develop rapidly 
and can be modified by their environment2 influencing 
their ability to learn and develop over time.3 Thus, early 
childhood is a key time to maximise the opportunity 
for children to develop their full potential. Researchers 
have shown that appropriate stimulation, good quality 
parenting provided by a consistent, responsive caregiver, 
coupled with adequate nutrition and access to health 
and psychosocial care can contribute to optimal develop-
ment.4 5 Conversely, adversities during this period, such 
as poverty, malnutrition, poor health, low stimulation, 
exposure to stressful conditions and impoverished envi-
ronment can disrupt brain development, attachment, 
and early learning.2
HIV infection in both the parent and the child 
represents a multifaceted life challenge.6 HIV can 
impact child growth and development in a variety of 
ways including their cognitive development.7 8 Several 
studies have described the risk of developmental delay 
and impairment in both children living with HIV,9 and 
HIV-exposed uninfected (HEU) infants7 compared 
with HIV-unexposed infants,8 with the risk apparently 
heightened in low-income and middle-income coun-
tries (LMICs).10 Children infected with HIV perinatally 
face greater risk of neurological and neuropsychological 
deficits compared with HEU infants, either due to direct 
effects of HIV on the central nervous system,9 exposure 
to treatment or other HIV-related factors. These risks 
can be mitigated; research illustrates the importance of 
early antiretroviral therapy (ART) initiation, and virolog-
ical suppression during infancy or early childhood and 
its association with improved neurocognitive outcomes 
in children with perinatally acquired HIV.11 12 HIV can 
also impact the neurodevelopment of children indirectly 
through its influence on the child’s living environment,8 
including community stigma and discrimination, care-
giver unemployment, caregiver illness and bereavement 
or caregiver mental health.10 13 14 However, in some cases 
despite facing significant adversities, HEU children can 
develop resiliency and demonstrate positive develop-
mental trajectories, similar to those HIV-unexposed 
uninfected.15
Early interventions for disadvantaged children have led 
to documented improvements in child outcomes such as 
survival, health, growth and cognitive and social devel-
opment.16 Several studies have demonstrated the bene-
fits of caregiver or child targeted interventions over the 
long term and showed improvements in developmental 
outcomes of children from LMICs.2 4 Home visits and 
support to HIV-positive caregivers by community health 
workers was found to improve developmental outcome 
for HEU children.17 Parenting and child stimulation 
programmes taught to the caregiver can significantly 
improve cognitive and motor development in young 
children infected with HIV.18 In addition, microfinance 
programmes (which includes the provision of loans, 
savings and insurance) in rural settings can have a posi-
tive impact on various household indicators, improve 
food security and the health of children.19 Research 
shows that combination interventions can have accel-
erated benefits.20 21 Theoretical models22 suggest that 
internal assets, family resources and community support 
can promote the resilience process and temper negative 
impacts of parental HIV. The need for an evaluation of 
more complex, broader and integrated interventions is 
timely.
Zimbabwe is one of the countries most severely 
affected by HIV globally, with prevalence estimated at 
14.6% among those aged 15–64 years.23 Over a million 
children have been orphaned due to AIDS-related deaths 
since the start of the epidemic.24 Prevention of mother to 
child transmission (PMTCT) programmes have dramat-
ically reduced perinatal transmission and ART rollout 
has reduced mortality and morbidity in caregivers.25 
However, despite improved health and survival of infants 
born to mothers living with HIV, interventions to improve 
the well-being and development of these children are 
needed. The Child Health Intervention for Develop-
mental Outcomes (CHIDO) trial aimed to determine the 
real-world effectiveness of a multicomponent communi-
ty-based intervention on child development and HIV.
MeTHods
The methods have been previously published.26 A brief 
overview is provided here.
study design and participants
The CHIDO trial is a pragmatic parallel-arm cluster 
randomised controlled trial conducted in 30 primary 
care clinic catchment areas in two districts in Zimbabwe 
(Goromonzi and Mudzi). Detailed mapping of all health 
facilities and their communities was conducted to select 
trial sites, which are at least 15 km apart.
Community sensitisation was carried out in phases. 
First, the local leaders (including traditional and political 
leaders, health and educational professionals) were given 
information about the study, its objectives, the target 
population and encouraged to ask questions or raise any 
concerns. They were then invited to take part in the site 
randomisation process. The caregivers were identified 
from the HIV-exposed infant registers kept at trial clinics 
and were eligible for inclusion if they were the primary 
caregivers (biological and non-biological), the biological 
mother had been living with HIV and cared for a child 
aged 0–24 months. Caregivers who gave written informed 
consent/assent in English or Shona were enrolled into 
the trial, completed a baseline assessment and were 
followed up after 12 months. In intervention communi-
ties, caregiver-infant dyads were encouraged to engage in 
all CHIDO intervention activities. While they attended 
the clinic specifically for the intervention sessions, they 
could also attend clinic services if scheduled/required.
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Table 1 Parenting programme content
Session number Delivered by Parenting programme content
1 CHW Relationships with people around you and your child
2 CHW The role of good parent—responsive parenting practices (session I)
3 CHW The role of good parent—responsive parenting practices (session II)
4 Nurse A healthy infant and young child (session I)
5 Nurse A health infant and young child (session II)
6 Nurse A well-nourished infant and young child
7 CHW Physical/motor development (session I)
8 CHW Physical/motor development (session II)
9 CHW Social and emotional development (session I)
10 CHW Social and emotional development (session II)
11 Nurse A health infant and young child (focus on PMTCT and treatment adherence)
12 Nurse Complementary feeding (session I)
13 Nurse Complementary feeding (session II)
14 CHW Communication and language development (session I)
15 CHW Communication and language development (session II)
16 CHW Developing thinking and understanding of the world (cognitive) (session I)
17 CHW Developing thinking and understanding of the world (cognitive) (session II)
18 CHW Positive discipline
CHW, Community Health Worker; PMTCT, Prevention of mother to child transmission.
Extended Consolidated Standards of Reporting Trials 
guidelines were followed for reporting the results of this 
trial.
Patient involvement
Patients and village health workers were involved in form-
ative work undertaken at which the CHIDO intervention 
was developed.
randomisation and masking
Clinics were randomised in a 1:1 allocation ratio to the 
CHIDO intervention or Ministry of Health and Child 
Care (MoHCC) standard of care. Restricted rando-
misation was used to ensure balance by district (20 in 
Goromonzi district and 10 in Mudzi district) and on the 
number of HIV-exposed infants aged between 0 and 24 
months per clinic by stratifying the clinics into those able 
to run one group of 12 dyads (12 clusters) and those of 
sufficient size to run two groups of 12 dyads (18 clusters). 
To maximise transparency and buy-in from stakeholders, 
a public randomisation procedure was undertaken in 
each district (on 19 January 2016 in Goromonzi and on 
31 May 2016 in Mudzi) involving MoHCC, and district-
level government and medical representatives. Assessors 
conducting the endline survey procedures were blind to 
trial arm.
Intervention components
The intervention included three elements: (i) an 
18-session health, nutrition and early childhood stim-
ulation (ECS) parenting programme (table 1); (ii) an 
internal savings and lending scheme (ISALS) with ISALS 
sessions held immediately after each ECS session and (iii) 
village health workers who visited participants at home 
each month (or more frequently in the case of non-at-
tendance at group sessions or other problems). The 
parenting programme content evolved out of formative 
work and the number of sessions was set after piloting 
and feedback from participants about preferred length 
and frequency of sessions.
baseline and endline assessments and data collection
Participant enrolment was conducted in parallel in inter-
vention and standard of care communities between 16 
January and 8 September 2016. At enrolment, all partic-
ipating caregiver-child dyads were allocated a unique 
identifier. Questionnaire data which included demo-
graphic, socioeconomic, maternal mental health and 
household food security information were collected 
using an interviewer-administered questionnaire with 
data entered directly onto tablets preprogrammed using 
Open Data Kit with range and consistency checks incor-
porated. Maternal mental health was measured using 
the Edinburgh Postnatal Depression Scale (EPDS),27 28 
which is a diagnostic tool that has been locally validated 
in Zimbabwe,28 plus the 8-item Shona Symptoms Ques-
tionnaire (SSQ-8), a locally developed and validated 
scale which determines risk of common mental disorders 
(including anxiety and depression).29 Finally, parental 
stress was measured using the Parental Stress Index Short 
Form (PSI-SF).30
 o
n
 Septem
ber 18, 2019 by guest. Protected by copyright.
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2019-001651 on 11 September 2019. Downloaded from 
4 Mebrahtu H, et al. BMJ Global Health 2019;4:e001651. doi:10.1136/bmjgh-2019-001651
BMJ Global Health
Table 2 Secondary outcomes of the CHIDO trial
Outcome measures Assessment tools used
Child HIV outcomes: viral load Viral load tests conducted using Biomerieux NucliSENS easyMag and 
EasyQ on dried blood spot samples
Child development outcomes:
 ► Visual reception
 ► Fine motor
 ► Receptive language
 ► Expressive language
Mullen early learning composite score
Nutritional outcomes: weight-for-age, height-for-
age, weight-for-height (BMI) z-scores
Midupper arm circumference tape measure, height mate/board
Parental stress Parental Stress Index Short Form
Adherence outcomes:
 ► Retention in care
 ► Viral load
Medical Adherence Rating Scale
Viral load tests conducted using Biomerieux NucliSENS easyMag and 
EasyQ on dried blood spot samples
Food security outcome Household hunger (food deprivation) scale—modified HFIAS (one item 
from each domain of the scale: i) uncertainty about household food 
supply; ii) insufficient quality and iii) insufficient food intake
Mental health outcomes:
 ► Postnatal depression
 ► Common mental disorders
Edinburgh Postnatal Depression Scale
Shona Symptom Questionnaire 8
BMI, body mass index; CHIDO, Child Health Intervention for Developmental Outcomes; HFIAS, Household Food Insecurity Access Scale.
The more sensitive questions were self-completed using 
audio computer-assisted survey instrument to maximise 
validity. This was followed by a developmental assessment 
of the child conducted by one of two trained research 
nurses. Developmental assessments were videoed, and a 
small randomly selected sample was reviewed by a highly 
experienced assessor. This was done as part of quality 
control and assurance, and to minimise differences 
between assessors.
Intervention implementation commenced within 
3 months of participant enrolment in all communities 
and ran over 12 months between 7 March 2016 and 7 
July 2017.
An endline assessment was conducted between 10 April 
2017 and 18 January 2018 among enrolled caregiver-child 
dyads 12 months after the baseline survey and within 0–5 
months after completion of intervention delivery. The 
endline survey was conducted in parallel, with pairs of 
intervention and control trial sites being assessed at the 
same survey venue to minimise unblinding of assessors. 
Survey procedures were as described at baseline.
At endline a dried blood spot sample was collected 
from all biological mothers to determine HIV viral load 
and infants to test for HIV antibody status and viral load. 
Programme attendance records and village healthcare 
worker diaries were reviewed, and data double entered 
into password protected Access databases.
Laboratory assessments
Dried blood spot samples were air dried, stored at room 
temperature and submitted weekly to the respective 
laboratories. Infant samples were sent to the National 
Microbiology Reference Laboratory in Harare for HIV-1 
antibody testing using COBAS AmpliPrep/COBAS 
TaqMan. Samples confirmed HIV positive were sent for 
viral load testing. Caregiver samples were sent to flow 
cytometry laboratory for viral load testing using Biomer-
ieux NucliSENS easyMag and EasyQ.
outcome measures
There were two primary outcomes for the trial: (i) change 
in the mean age-standardised Mullen early learning 
composite (ELC) score31 of children; (ii) the proportion 
of HIV-exposed or HIV-positive children with full reten-
tion in care (>80%) of scheduled HIV treatment and care 
visits at 12 months. In the absence of locally validated 
robust child development measures, the Mullen ELC 
score was chosen as it had been used to determine impact 
of caregiver interventions over a similar time period in 
Africa.32 33 We assessed seven prespecified secondary end 
points as previously reported, reflecting factors intended 
to be affected by the intervention, which were analysed 
by the same analytical framework as the primary outcome 
(table 2).
statistical analysis
Our sample-size calculations have been described previ-
ously.26 We estimated that we would need 15 clusters 
per arm with a harmonic mean of 16 caregiver-child 
dyads per cluster at endline, and assuming 20% loss to 
follow-up over 12 months to have 80% power to detect 
an effect size (difference in means/SD) of 1.23 for the 
Mullen ELC score and 82% power to detect a risk differ-
ence in retention in care of HIV-exposed children of 
at least 17% assuming 65% are retained in the control 
arm. The overall recruitment target was therefore 
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Figure 1 Recruitment and enrolment.
528 caregiver-child dyads in total from 30 clinics. We 
recruited 574 dyads to ensure a harmonic mean of 24 
dyads was enrolled from the larger seven clinics (to allow 
two groups to run at these sites) and a harmonic mean 
of 12 dyads was enrolled from the smaller eight clinics, 
where just one ECS/ISALS group was run.
The statistical analysis followed a prespecified analyt-
ical plan differing from the published protocol by using 
individual-level analysis (see online supplementary mate-
rials), which allowed for greater flexibility. Data were 
analysed in STATA V.15.1 (StataCorp, College Station, 
Texas, USA) using intention-to-treat principles incorpo-
rating random effects for clusters and adjusting mini-
mally for baseline prognostic factors. Mean differences 
and 95% CIs were used to estimate the effect of the inter-
vention for quantitative outcomes using mixed effects 
linear regression. ORs and 95% CI were used to estimate 
the effect of the intervention for binary outcomes using 
mixed effects logistic regression. Mental health questions 
were categorised as at risk or not at risk, with cut-points of 
12/30 for the EPDS,28 6/8 for the SSQ-829 and at the 90th 
percentile of the reference range for PSI-SF domain and 
total scores.30 Baseline factors adjusted for a priori were 
the baseline measurement, strata in Goromonzi (two 
groups based on the number of children on the clinic 
register), district (Goromonzi or Mudzi), infant age (0 
to <6 months, 6 to <12 months and 12–24 months) and 
for quantitative Mullen outcomes, a categorical covariate 
representing the assessor at baseline. Sensitivity analyses 
were performed using a cluster-level analysis for the ELC 
score.34 Evidence for effect modification in the ELC score 
was assessed by incorporating interaction terms with base-
line Mullen ELC score or with baseline caregiver’s mental 
health as measured by EPDS, SSQ-8 and PSI-SF. The 
effect of the intervention was also examined in a per-pro-
tocol analysis comparing those in the intervention arm 
who attended most ECS sessions (either at least 14/18 
sessions in total, or at least 7/9 sessions addressing child 
development) with those in the standard of care arm.
resuLTs
All 30 clusters were randomised (15 to each trial arm) and 
all remained in the trial until the end (figure 1). Number 
of participants recruited (n=574) exceeded target enrol-
ment (n=528). Retention was 89.5% (514/574) (261: 
91.5% in the intervention arm and 253: 85.0% in the 
standard of care arm), of whom 506 of 514 had endline 
data on the Mullen score. Six Mullen scores were missing 
because the child had died. The other two children 
were found and tested for HIV but the Mullen test was 
not performed. At follow-up, 18 children had a different 
primary caregiver from the person who completed the 
baseline interview.
descriptive characteristics at baseline
Baseline characteristics were generally comparable 
between trial arms (table 3); the intervention arm had 
a greater percentage of infants aged under 6 months 
(26.3% vs 15.0%), infants stunted at baseline (38.4% vs 
34.3%) and households of lower socioeconomic status 
(37.0% vs 30.0%). Only two of seven HIV-infected babies 
had been started on ART within 6 weeks of birth. Almost 
all caregivers (562/574; 97.9%) were biological mothers, 
and about half (304/574; 53.0%) had secondary educa-
tion or higher. Reported food insecurity was high. Mental 
health of caregivers was poor with 230/574 (40.1%) 
caregivers at risk of common mental disorders (SSQ-8 
>6) and about half of mothers (284/562; 49.5%) above 
the threshold for postnatal depression (EPDS >12) at 
baseline. High parental distress (PSI-SF parental distress 
subscale >90th percentile) was reported by 185/574 
(32.2%) caregivers.
Infants were 291/574 (50.1%) female, and 207/574 
(36.1%) were stunted (WHO height-for-age z-score <–2). 
The mean composite score on the Mullen ELC score at 
baseline was 102.3 (95% CI 98.6 to 106.0), which was 
similar to the US reference norms (table 3). Character-
istics of those lost to follow-up were similar to those who 
completed follow-up (online supplementary appendix 
table 1).
Programme implementation
The CHIDO intervention was initiated in all 15 interven-
tion clusters, with 281 participants enrolled. There are 
missing attendance data from one cluster. In the 14 clus-
ters with attendance data, 21 ECS groups were run with 
each group intended for up to 12 participants. Seven 
clusters ran one group and seven clusters ran two groups. 
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Table 3 Descriptive characteristics of participants at baseline by trial arm
Measure and level Intervention arm Standard of care arm
Total N (% of total) 281 (49.0%) 293 (51.0%)
Infant’s characteristics       
Age (years) Median (IQR) 1.04 (0.48–1.49) 1.00 (0.68–1.47)
Age (months) 0 to <6 74 (26.3%) 44 (15.0%)
  6 to <12 61 (21.7%) 100 (34.1%)
  12–24 146 (52.0%) 149 (50.9%)
Sex N (%)     
  Male 141 (50.2%) 142 (48.5%)
  Female 140 (49.8%) 151 (51.5%)
HIV status as reported at baseline N (%)     
  True positive 2 (0.7%) 3 (1.0%)
  False positive 7 (2.5%) 1 (0.3%)
  Unconfirmed positive 3 (1.1%) 2 (0.7%)
  True negative 155 (55.2%) 184 (62.8%)
  False negative 6 (2.1%) 2 (0.7%)
  Unconfirmed negative 11 (3.9%) 31 (10.6%)
  Prefers not to say 2 (0.7%) 0 (0%)
  Unknown 95 (33.8%) 70 (23.9%)
HIV status as reported at 12 months N (%)     
  True positive 5 (1.8%) 4 (1.4%)
  False positive 1 (0.4%) 2 (0.7%)
  True negative 236 (84.0%) 231 (78.8%)
  False negative 5 (1.8%) 2 (0.7%)
  Unconfirmed negative 1 (0.4%) 2 (0.7%)
  Prefers not to say 1 (0.4%) 2 (0.7%)
  Unknown (negative) 9 (3.2%) 7 (2.4%)
  Lost to follow-up 23 (8.2%) 43 (14.7%)
HIV status as known at 12 months N (%)     
  Infected 10 (3.6%) 6 (2.0%)
  Exposed uninfected 247 (87.9%) 242 (82.6%)
  Unknown 1 (0.4%) 2 (0.7%)
  Lost to follow-up 23 (8.2%) 43 (14.7%)
Birth weight (kg) Mean (95% CI) 2.99 (2.90 to 3.08) 
n=272
2.93 (2.86 to 3.00) 
n=283
Weight-for-age z-score Mean (95% CI) −0.86 (−1.15 to −0.57) −0.86 (−0.99 to −0.72)
Underweight (z-score <–2) Yes 44 (15.7%) 43 (14.7%)
  No 237 (84.3%) 250 (85.3%)
Length-for-age z-score Mean (95% CI) −1.56 (−1.87 to −1.25) −1.46 (−1.71 to −1.21)
Stunted (z-score <−2) Yes 107 (38.4%) 100 (34.3%)
  No 172 (61.7%) 192 (65.8%)
BMI z-score       
Low BMI z-score Yes 15 (5.4%) 17 (5.8%)
  No 264 (94.6%) 275 (94.2%)
MUAC z-score       
Low MUAC z-score <-2 Yes 14 (6.0%) 15 (5.8%)
Continued
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Measure and level Intervention arm Standard of care arm
  No 218 (94.0%) 246 (94.3%)
Mullen scales (T-scores) Mean (95% CI)     
  Expressive language 52.4 (49.7 to 55.1) 53.1 (51.3 to 55.0)
  Fine motor 51.1 (47.9 to 54.4) 50.2 (47.4 to 53.0)
  Gross motor 50.1 (47.7 to 52.6) 50.8 (49.2 to 52.4)
  Receptive language 47.6 (44.5 to 50.8) 47.6 (44.8 to 50.4)
  Visual reception 53.5 (49.3 to 57.8) 52.6 (50.2 to 55.1)
  Early learning composite 
score
102.6 (96.5 to 108.7) 102.0 (97.8 to 106.3)
Caregiver’s characteristic       
Caregiver type N (%)     
  Mother 272 (96.8%) 290 (99.0%)
  Other 9 (3.2%) 3 (1.0%)
Age (years) Median (IQR) 32 (27–36) 32 (27–36)
Marital status N (%)     
  Married 227 (81.1%) 228 (77.8%)
  Divorced/separated 32 (11.4%) 42 (14.3%)
  Widowed 16 (5.7%) 15 (5.1%)
  Never married 5 (1.8%) 8 (2.7%)
Education N (%)     
  Secondary or above 152 (54.1%) 152 (51.9%)
Employment N (%)     
  Employed 90 (32.0%) 120 (41.0%)
SES N (%)     
  Lowest 104 (37.0%) 88 (30.0%)
  Middle 100 (35.6%) 91 (31.1%)
  Highest 77 (27.4%) 114 (38.9%)
Parental stress score (PSI-SF) N (%)     
Parental distress subscale n=565 Not stressed (<90th 
percentile)
188 (68.4%) 192 (66.2%)
  Stressed (≥90th 
percentile)
87 (31.6%) 98 (33.8%)
Parent-child interaction dysfunction subscale 
n=565
Not stressed (<90th 
percentile)
169 (61.2%) 182 (63.0%)
  Stressed (≥90th 
percentile)
107 (38.8%) 107 (37.0%)
Difficult child subscale n=563 Not stressed (<90th 
percentile)
241 (87.3%) 240 (83.6%)
  Stressed (≥90th 
percentile)
35 (12.7%) 47 (16.4%)
PSI-SF total score n=564 Not stressed (<90th 
percentile)
180 (65.7%) 185 (63.8%)
  Stressed (≥90th 
percentile)
94 (34.3%) 105 (36.2%)
Mother’s viral load copies/mL n=485 Geometric mean (SD) 126.2 108.0
  N (%) failure (≥1000 
copies/mL)
33/246 (13.4%) 25/239 (10.5%)
Table 3 Continued
Continued
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Measure and level Intervention arm Standard of care arm
Maternal mental health (EPDS) n=562 N (%)     
  Not depressed (score 
0–11)
132 (48.5%) 146 (50.3%)
  Depressed (score≥12) 140 (51.4%) 144 (50.0%)
Common mental disorders (SSQ-8) n=573 N (%)     
  No CMD (score 0–5) 168 (60.0%) 175 (60.0%)
  CMD (score 6–8) 112 (40.0%) 118 (40.0%)
Household food security (HFIAS) N (%)     
  Little to no hunger 116 (41.3%) 126 (43.0%)
  Moderate-to-severe 
hunger
165 (58.7%) 167 (57.0%)
Medical Adherence Rating Scale n=560 Not adherent 8 (3.0%) 5 (1.7%)
  Adherent 263 (97.1%) 284 (98.3%)
BMI, body mass index; CMD, Common mental disorders; EPDS, Edinburgh Postnatal Depression Scale; HFIAS, Household Food Insecurity 
Access Scale; MUAC, mid-upper arm circumference; PSI-SF, Parental Stress Index Short Form; SES, socioeconomic status; SSQ-8, 8-item 
Shona Symptoms Questionnaire.
Table 3 Continued
Figure 2 Early childhood stimulation (ECS) session 
attendance. Orange bars indicate sessions focusing on 
child development (n=281 all trial participants; n=268 trial 
participants in communities that recorded ECS; n=232 who 
ever enrolled in a session).
Of 268 caregivers in the intervention arm from the 14 
clusters with records, 232 (86.6%) attended any ECS 
session. There were 43/268 (16.0%) participants who 
attended all 18 ECS sessions, and 118/268 (44.0%) who 
attended 14–17 sessions. Of the nine sessions addressing 
child development (table 1 and figure 2), 79/268 
(29.5%) participants attended all nine sessions, and 
79/268 (29.5%) attended seven or eight sessions, median 
per group who attended seven to nine child development 
sessions was 7.5 (IQR 6–9).
ISALS ran immediately after the ECS sessions and all 
women who attended an ECS session were assumed to 
have attended an ISALS session. Women were recorded 
in the ISALS register if they made a financial contribu-
tion to the ISALS (ie, actively participated in the ISALS 
process). The target was for women to participate in 12 
ISALS over the course of the trial. ISALS registers were 
not available for five clusters. Where records were kept, 
184 of the 232 caregivers (79.3%) participated in at 
least one ISALS session and 155 (67%) made a financial 
contribution. The median number of sessions attended 
at which a financial contribution was made was 5 (IQR 
2–9), and 14/232 (6.0%) made a financial contribution 
at least 12 times (equivalent to once monthly). Overall, 
198/232 (85.3%) received at least one home visit and the 
median number of home visits per caregiver was seven 
(IQR 0–9). Impact evaluation was assessed a median 134 
(IQR 98–163) days after participants attended their last 
ECS session among 232 participants who attended any 
session and were followed up.
Among all intervention participants, only 32.4% 
(91/281) were recorded as having received the full 
intervention package as devised (>14 ECS, >6 ISALS and 
>6 home visits) (figure 3).
Primary outcomes 
Early learning composite score
At the endline survey the Mullen ELC mean score was 
87.9, a reduction of 14.4 points from baseline. There 
was no evidence of a difference in Mullen composite 
score after programme implementation between trial 
arms (mean of 88.1 in the intervention arm and 87.6 
in standard of care arm; adjusted mean difference 
(aMD)=0.06; 95% CI −2.68 to 2.80). The estimated coeffi-
cient of variation (k) was 0.09. Cluster-level means showed 
departure from normality, but results were comparable 
(aMD=0.11; 95% CI −2.90 to 3.11). There was also no 
evidence of difference in Mullen subscales by trial arm 
(table 4). Individual child trajectories showed that 80% 
of infants had lower ELC scores at follow-up compared 
with baseline in both arms.
There was no evidence for effect modification for the 
prespecified baseline covariates on the intervention 
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Figure 3 Venn diagram of trial participant attendance at 
intervention sessions. ECS, early childhood stimulation; HV, 
home visit; ISALS, internal savings and lending scheme.
Table 4 Primary outcomes
Outcome Intervention arm Standard of care arm
Adjusted mean 
difference* 
(95% CI)
Measure 
of effect 
(95% CI)
Coefficient of 
variation (k)
Mullen scales (T-scores), 
mean (95% CI), adjusted 
mean difference
n=257 n=249
Early learning composite 
score
88.1 (84.0, 92.2) 87.6 (83.1, 92.1) 0.06 (−2.68 to 
2.80)
p=0.97
– 0.09
Expressive language Mullen 
scale
44.9 (43.1, 46.7) 45.3 (43.3, 47.3) −0.44 (−2.03 to 
1.14)
p=0.58
−0.44 (−2.03 
to 1.14)
p=0.58
Receptive language Mullen 
scale
45.3 (43.1, 47.5) 45.8 (43.1, 48.4) −0.11 (−1.82 to 
1.60)
p=0.90
−0.11 (−1.82 
to 1.60)
p=0.90
Fine motor Mullen scale 41.7 (39.3, 44.2) 41.0 (38.5, 43.6) −0.23 (−2.38 to 
1.92)
p=0.83
−0.23 (−2.38 
to 1.92)
p=0.83
Gross motor Mullen scale 50.2 (47.7, 52.6)
n=196
48.2 (45.4, 51.0)
n=201
1.99 (−0.54 to 
4.51)
p=0.12
1.99 (−0.54 to 
4.51)
p=0.12
Visual reception Mullen 
scale
42.8 (40.1, 45.5) 41.5 (38.6, 44.4) 0.84 (−1.44 to 
3.12)
p=0.47
0.84 (−1.44 to 
3.12)
p=0.47
Child retention in HIV care 201/257 (78.2%) 207/249 (83.1%) – OR=0.73 (0.47 
to 1.14
p=0.16
Virological failure children 
as proportion of those HIV 
positive
4/8 (50%) 4/6 (67%) – –
Virological failure mothers 33/246 (13.4%) 25/239 (10.5%) – OR=1.33 (0.72 
to 2.46)
p=0.36
*Positive mean difference indicates that those in the intervention arm have higher Mullen scores.
effect on the Mullen score (table 5). Defining adequate 
provision of ECS as attendance at 14 or more sessions, 
there was no evidence of an intervention effect among 
those receiving adequate provision (aMD=0.57; 95% CI 
−2.39 to 3.53) compared with the standard of care arm.
Child HIV retention in care
At follow-up, infant HIV prevalence was 3.9% (10/257) in 
the intervention arm and 2.4% (6/248) in the standard 
of care arm. Clinic attendance data were not collected. 
Two proxy measures for HIV care retention were used. 
First, in HIV-positive children the prevalence of viro-
logical failure (viral load >1000 copies/mL) was 4/8 
(50.0%) in the intervention arm (with two missing test 
results) and 4/6 (66.6%) in the standard of care arm. 
The numbers were too small to detect any difference 
between arms in HIV prevalence or viral suppression. 
Second, the date of the most recent HIV test was recorded 
at baseline and follow-up. Children were recorded as not 
retained in care if they had missed an HIV test in the 
PMTCT schedule (at 6 weeks, 9 months and weaning). 
 o
n
 Septem
ber 18, 2019 by guest. Protected by copyright.
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2019-001651 on 11 September 2019. Downloaded from 
10 Mebrahtu H, et al. BMJ Global Health 2019;4:e001651. doi:10.1136/bmjgh-2019-001651
BMJ Global Health
Table 5 Effect modification of the intervention effect by baseline characteristics
Covariate Level
Mean Mullen ELC after programme 
implementation
Intervention arm
Standard of care 
arm
P value for effect 
modification
Baseline ELC score Below average (Mullen 
ELC <85)
78.5 79.2
Average+(Mullen ELC≥85) 90.1 89.1 0.91
Baseline EPDS Not showing signs of 
depression (EPDS score 
<12)
89.7 88.5
Showing signs of 
depression (EPDS 
score≥12)
86.5 86.5 0.78
Baseline SSQ-8 No CMD (SSQ-8<6) 89.7 88.6
CMD (SSQ-8≥6) 85.7 86.1 0.51
Baseline PSI-
PDparental distress 
subscale
Not showing signs of 
distress (PSI-PD<90th 
percentile)
87.7 88.3
Showing signs of distress 
(PSI-PD≥90th percentile)
89.2 85.9 0.54
Baseline infant’s age 
(month)
0 to <6 88.5 89.1
6 to <12 89.6 86.7
12–24 87.3 87.8 0.70
ELC, early learning composite; EPDS, Edinburgh Postnatal Depression Scale; PSI-PD, Parental Stress Index parental distress subscale; 
SSQ-8, 8-item Shona Symptoms Questionnaire.
In the intervention arm 21.8% of infants had missed the 
most recent test, compared with 16.9% in the standard of 
care arm (adjusted OR (aOR)=1.25; 95% CI 0.77 to 2.01, 
p=0.37).
At baseline, 165/574 (28.7%) of caregivers said they 
did not know the child’s HIV status and by follow-up only 
16/506 (3.1%) said they did not know (table 3). There 
was no difference between arms in reported knowledge 
of HIV status at follow-up. At follow-up in the interven-
tion arm 79/85 (92.9%) of caregivers who at baseline 
reported not knowing child’s status reported they now 
knew it, compared with 55/58 (94.8%) in the standard 
of care arm.
secondary outcomes
Nutritional outcomes
There was no evidence of any impact of the intervention 
on weight-for-age z-score, height-for-age z-score or body 
mass index (table 6), although there was strong evidence 
that infants in the intervention arm had a reduced mean 
MUAC for z-score (−0.60 vs −0.49; aMD=−0.20; 95% CI 
−0.35 to 0.06; p=0.01).
Parenting stress
There was weak evidence of an intervention effect on 
parental stress overall (aOR=0.69; 95% CI 0.45 to 1.05; 
p=0.08). There was strong evidence that the intervention 
had an impact on the parental distress subscale of the PSI 
(17.4% vs 29.1%; aOR=0.56; 95% CI 0.35 to 0.89; p=0.01).
Maternal adherence outcomes
The proportion of women with viral loads of >1000 
copies/mL was similar by arm (13.4% in the interven-
tion arm vs 10.5% in the standard of care arm; aOR=1.33; 
95% CI 0.72 to 2.46). Self-reported adherence on the 
Medical Adherence Rating Scale was high at follow-up 
and also similar between trial arms (97.6% in the inter-
vention arm vs 98.4% in the standard of care arm; online 
supplementary appendix table 1).
Household food security
There was no evidence of difference in household food 
security by trial arm, with 24.9% in the intervention arm 
and 21.7% in the standard of care arm reporting experi-
encing food insecurity (aMD=1.19; 95% CI 0.62 to 2.26; 
p=0.52).
Maternal mental health outcomes
There was no evidence of a difference between trial arms 
in the proportion of biological mothers with at least mild 
postnatal depression measured using the EPDS (39.8% vs 
43.9%; aOR=0.79; 95% CI 0.50 to 1.25; p=0.32), despite 
symptoms of postnatal depression being common 
(table 6). There was also no difference observed among 
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Table 6 Secondary outcomes
Outcome Intervention arm n=257
Standard of care arm 
n=249
Measure of effect 
(95% CI)
Weight-for-age z-score, mean (95% CI), 
adjusted mean difference
−0.96 (−1.09 to −0.84) −0.85 (−0.97 to −0.72) −0.13 (−0.28 to 0.03)
p=0.10
Underweight, n (%), adjusted OR   
No 224 (86.8%) 222 (88.8%) 1
Yes 34 (13.2%) 28 (11.2%) 1.24 (0.62 to 2.47)
p=0.54
Height-for-age z-score, mean (95% CI), 
adjusted mean difference
−1.36 (−1.61 to −1.12) −1.34 (−1.49 to −1.20) −0.06 (−0.24 to 0.11)
p=0.49
Stunted, n (%), adjusted OR   
No 184 (71.3%) 189 (75.6%) 1
Yes 74 (28.7%) 61 (24.4%) 1.23 (0.79 to 1.93)
p=0.36
BMI-for-age z-score, mean (95% CI), 
adjusted mean difference
−0.16 (−0.48 to 0.15) −0.01 (−0.20 to 0.18) −0.14 (−0.39 to 0.10)
p=0.26
Low BMI-for-age z-score, n (%), adjusted 
OR
  
No 239 (92.6%) 237 (94.8%) 1
Yes 19 (7.4%) 13 (5.2%) 1.45 (0.68 to 3.05)
p=0.34
MUAC-for-age z-score, mean (95% CI), 
adjusted mean difference
−0.60 (−0.75 to −0.45) −0.49 (−0.61 to −0.38) −0.20 (−0.35 to −0.06)
p=0.006
Low MUAC-for-age z-score, n (%), 
adjusted OR
  
No 245 (95.0%) 244 (97.6%) 1
Yes 13 (5.0%) 6 (2.4%) 1.63 (0.53 to 496)
p=0.39
PSI-SF percentile≥90%, n (%), adjusted 
OR
  
No 185 (71.7%) 161 (63.6%) OR=1
Yes 73 (28.3%) 92 (36.4%) OR=0.69 (0.45 to 1.05)
p=0.08
PSI-SF percentile, mean (95% CI), 
adjusted mean difference
76.8 (73.0 to 80.4) 76.2 (70.5 to 81.9) 0.44 (–5.18 to 6.05)
p=0.88
Parental distress subscale 
percentile>90%, n (%), adjusted OR
  
No 213 (82.6%) 178 (70.9%) OR=1
Yes 45 (17.4%) 73 (29.1%) OR=0.56 (0.35 to 0.89)
p=0.01
Parental distress subscale, mean 
(95% CI), adjusted mean difference
65.0 (60.1to 70.0) 66.6 (60.2 to 72.9) −0.15 (−7.16 to 6.86)
p=0.97
Parent-child dysfunctional interaction 
subscale percentile≥90%, n (%), adjusted 
OR
  
No 157 (60.6%) 152 (60.1%) OR=1
Yes 102 (39.3%) 101 (39.9%) OR=1.00 (0.63 to 1.59)
Parent-child dysfunctional interaction 
subscale, mean (95% CI), adjusted mean 
difference
74.0 (68.3 to 79.7) 72.7 (65.8 to 79.6) −0.02 (−6.16 to 6.12)
p=0.99
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Outcome Intervention arm n=257
Standard of care arm 
n=249
Measure of effect 
(95% CI)
Difficult child subscale percentile≥90%, n 
(%), adjusted OR
  
No 203 (78.3%) 186 (73.5%) OR=1
Yes 56 (21.6%) 67 (26.5%) OR=0.79 (0.46 to 1.38)
p=0.41
Difficult child subscale, mean (95% CI), 
adjusted mean difference
70.0 (65.5 to 74.5) 70.0 (66.0 to 73.2) 0.73 (−4.34 to 5.79)
p=0.78
High EPDS, n (%), adjusted OR   
No 148 (60.2%) 134 (56.1%) 1
Yes 98 (39.8%) 105 (43.9%) 0.79 (0.50 to 1.25)
p=0.32
High SSQ-8, n (%), adjusted OR   
No 144 (55.2%) 138 (54.6%) 1
Yes 117 (44.8%) 115 (45.5%) 0.90 (0.62 to 1.32)
p=0.59
Household food security (HFIAS), n (%), 
adjusted OR
  
Little to no hunger 196 (75.1%) 198 (78.3%) 1
Moderate-to-severe hunger 65 (24.9%) 55 (21.7%) 1.19 (0.62 to 2.26)
p=0.52
BMI, body mass index; EPDS, Edinburgh Postnatal Depression Scale; HFIAS, Household Food Insecurity Access Scale; MUAC, mid-upper 
arm circumference; PSI-SF, Parental Stress Index Short Form; SSQ-8, 8-item Shona Symptoms Questionnaire.
Table 6 Continued
those at risk for common mental disorders (44.8% vs 
45.5%; aOR=0.90, 95% CI 0.62 to 1.32; p=0.59).
dIsCussIon
We undertook a pragmatic evaluation of a multicompo-
nent group intervention combining sessions addressing 
early childhood stimulation and more general childcare 
with household economic strengthening to improve food 
security and economic barriers to clinic attendance. We 
aimed to improve global child development and retention 
in HIV care of infants born to HIV-positive mothers both 
by targeting these outcomes and some of their structural 
drivers. There was no effect of the intervention on global 
child development within 4.5 months of completing the 
intervention. HIV retention in care was almost universal 
in both arms of the trial by endline. Only 32% of those 
in the intervention arm were confirmed to have received 
the full intervention package. Participants reported high 
levels of food insecurity, symptoms of anxiety and depres-
sion and parenting stress at baseline, all factors which 
are likely to impede participation. The intervention had 
no effect on any of these secondary outcomes except 
parental distress. Of note, the intervention was evalu-
ated in rural communities requiring some participants to 
travel considerable distances to attend sessions.
Although evidence from LMIC is limited, studies have 
demonstrated that ECS programmes targeting young 
children in these settings can improve global child 
development both in the short term and long term.4 35 
However, few have been delivered to HEU children. Many 
of these interventions have focused just on single inter-
ventions (such as nutrition, positive parenting practices) 
while this trial has looked at a more comprehensive 
package which addressed the wider structural barriers to 
early childhood development in addition to global chid 
development per se.
This intervention implemented by the Bantwana Initia-
tive of World Education was innovative in seeking to 
reach groups of caregivers rather than individuals and 
combine ECS training with training on more general 
child care issues. In addition, the intervention aimed to 
strengthen household economic security through ISALS 
both to improve food security (and thereby nutritional 
status of the child) and reduce economic barriers to 
clinic attendance. In practice, uptake of the interven-
tion was suboptimal possibly reflecting the acceptability 
of the intervention to some of the potential beneficia-
ries. Process evaluation suggested that using a group 
approach for mothers living with HIV was potentially stig-
matising, in that some women feared participation might 
result in deductive disclosure within the community. The 
distance caregivers had to travel to take part in interven-
tion sessions in some sites also undermined attendance. 
In addition, although the majority of women attended 
ISALS sessions relatively few opted to participate in the 
savings and lendings process perhaps reflecting their 
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reluctance to trust women in a group they were assigned 
to. Outside of the trial this intervention is offered to all 
mothers/caregivers of small children in a community 
and mothers are free to choose whether or not to join an 
ISALS and with whom. By evaluating the intervention we 
imposed artificial constraints on its delivery.
The trial occurred while the Zimbabwe Ministry of 
Health and Child Care and partners were strengthening 
prevention of mother to child transmission programmes. 
Option B+ was scaled up across Zimbabwe in 2014 and 
several studies have shown increasing engagement of 
mothers with services although engagement of infants 
in the care cascade has been less marked. Our findings 
suggest substantial improvements in knowledge of infant 
HIV status over the trial with knowledge of status near 
universal after 12 months in both arms. Reassuringly 
few children are HIV positive (3%) post-breast feeding, 
although among the few with HIV, a substantial propor-
tion in both arms had a detectable viral load, implying 
suboptimal engagement with care. Over 90% of women 
in both arms were virologically suppressed, higher than 
among women living with HIV in Zimbabwe generally 
(86%).36 This suggests that Zimbabwean mothers are 
optimally engaged in care and that our intervention 
could not substantially contribute to this.
There was some evidence of an intervention effect on 
parenting stress overall and distress specifically. However, 
the intervention did not affect risk of other common 
mental disorders. Of note, the intervention was not 
designed to address maternal mental health specifically. 
Caregivers in this trial had a high prevalence of risk of 
common mental disorder symptoms; around 50% of 
women were above the cut-off for mild postnatal depres-
sion at baseline and endline. Previous studies suggest that 
maternal depression negatively impacts both parenting 
and child development and this may have undermined 
our ability to demonstrate an impact. Future interven-
tions may need to incorporate a specific mental health 
component. The treatment gap for mental health in 
much of Africa is extremely high community-based lay 
health worker problem-solving therapy, such as the 
Friendship Bench which has been widely scaled up 
in urban Zimbabwe presents a method of closing the 
gap. Implementation of an adapted Friendship Bench 
through primary health clinics in rural areas is currently 
being explored.
We assessed global child development using the 
Mullen ELC score which is widely used but not validated 
or normed among African children of this age. It is a 
complex instrument and despite comprehensive training 
and limiting the number of trained assessors our inde-
pendent review of instrument implementation found that 
assessment of children was suboptimal. Of note though, 
the Mullen ELS has been successfully used elsewhere in 
Africa to determine the impact of a caregiver interven-
tion after 12 months.32 When compared with normative 
data (US-based), the baseline data on child develop-
ment score ranges were comparable, but by 12 months 
follow-up the scores were lower than normative groups. 
All children in the study were, by definition, HIV-exposed 
and there is a solid evidence base that both HIV expo-
sure and infection are associated with child development 
challenges.
Although there were no short-term effects on cognitive 
development for children, the fact that the endline data 
collection occurred a median of 4.5 months after inter-
vention completion may be important. The child devel-
opment benefit of parenting training may need more 
time to influence child development outcomes, particu-
larly as the child stimulation components of the course 
were scheduled at the end of the package and the impact 
of reduced parental stress on parenting behaviours may 
take time to be observed.
Strengths of our study included that we piloted research 
and intervention components to optimise our implemen-
tation and evaluation approach. We ran a large trial and 
had a high retention rate (90%) over 12 months. The 
trial was conducted independently of programme imple-
menters. We measured child development outcomes 
using assessors blinded to trial arm and undertook an 
independent validation of these measures. HIV retention 
in care was validated using biological markers. Mental 
health outcomes were all assessed using locally validated 
scales.
However, there are some limitations. By recruiting 
from the HIV-exposed infant registry, children who were 
not engaged in care were not included. This could have 
introduced some bias, excluding those least engaged in 
care and potentially most vulnerable. Measurement of 
global child development was suboptimal and we are 
uncertain as to what impact this has had on the global 
child development outcomes. However, we minimised 
number of Mullen ELC assessors and assessors deter-
mined outcomes in intervention and control arms. More 
time and resources for training and validation of assess-
ment procedures was required. Programme uptake was 
measured using programme implementer data and the 
apparently low programme uptake may reflect incom-
plete data collection by lay facilitators rather than poor 
attendance. As outlined above, the intervention design 
was adapted to fit the constraints of the trial evaluation 
design which may have adversely affected outcomes. A 
shorter ECS programme may be more practical to imple-
ment. The nature of the intervention was ambitious both 
in complexity and duration. Our study suggests that 
fidelity to the lengthy programme may be a challenge, but 
that the intertwining of interventions was feasible. Single 
interventions may flounder when real-life complexity is 
not addressed. Parenting in poverty and the presence of 
HIV is a complex reality. Our hypothesis was that a multi-
component intervention which addresses both ECD and 
its structural drivers was feasible and acceptable to some; 
the data on attendance can serve as a guide to future 
intervention planning. HIV-specific interventions, even 
if they are not labelled as such, may be stigmatising and 
may hinder attendance.
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Our trial has important implications for programmers 
and policy makers. Causes of poor child development in 
HIV-affected children are clearly multifactorial, but the 
feasibility and scalability of addressing multiple factors 
in a single multicomponent intervention is challenging. 
Given the high rates of poor mental health, effective 
community-based mental health interventions need to be 
scaled up beyond urban areas and potentially run along-
side ECS interventions. Design and implementation of 
evaluations of real-world interventions face several chal-
lenges including fitting within donor funding cycles, 
limited by implementer priorities and political realities, 
all of which are crucial factors.
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